FibroGen (FGEN) Reports Q1 Loss of $0.53/Share

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.53), versus ($0.50) reported last year. Revenue for the quarter came in at $22.86 million, versus $31.93 million reported last year.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance